Up a level |
Nixon, GL, Moss, DM, Shone, AE, Lalloo, DG ORCID: 0000-0001-7680-2200, Fisher, N, O'Neill, PM ORCID: 0000-0003-4338-0317, Ward, SA and Biagini, GA
(2013)
Antimalarial pharmacology and therapeutics of atovaquone.
Journal of Antimicrobial Chemotherapy, 68 (5).
pp. 977-985.
David Hong, W, Leung, SC, Amporndanai, K, Davies, J, Priestley, RS, Nixon, GL, Berry, NG ORCID: 0000-0003-1928-0738, Samar Hasnain, S, Antonyuk, S ORCID: 0000-0002-2779-9946, Ward, SA et al (show 2 more authors)
(2018)
Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties.
ACS Medicinal Chemistry Letters, 9 (12).
pp. 1205-1210.
Hong, WD, Gibbons, PD, Leung, SC, Amewu, R ORCID: 0000-0002-4676-436X, Stocks, PA, Stachulski, AV, Horta, PC, Cristiano, MLS, Shone, AE, Moss, D et al (show 13 more authors)
(2017)
Rational Design, Synthesis and Biological Evaluation of Heterocyclic Quinolones Targeting the respiratory chain of Mycobacterium tuberculosis.
Journal of medicinal chemistry, 60 (9).
pp. 3703-3726.
O'Neill, PM ORCID: 0000-0003-4338-0317, Amewu, RK ORCID: 0000-0002-4676-436X, Charman, SA, Sabbani, S, Gnädig, NF, Straimer, J, Fidock, DA, Shore, ER, Roberts, NL, Wong, MH-L et al (show 38 more authors)
(2017)
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.
Nature Communications, 8 (1).
15159-.